Novel telomere-targeting dual-pharmacophore dinucleotide prodrugs for anticancer therapy
Ilgen Mender(The University of Texas Southwestern Medical Center), Sergei Gryaznov(Department of Biotechnology)
Cited by 1
Related Papers
Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma
|Molecular Cancer Therapeutics|2023|14